Omega Flex, Inc. — Form 10-Q Summary
Business Context and Reporting Period
Omega Flex manufactures flexible metal hose and piping used in residential and commercial gas piping, industrial, petrochemical, pharmaceutical, transportation and other applications. Products are manufactured primarily in Exton, Pennsylvania, with limited U.K. production, and sold through distributors, wholesalers, sales representatives and OEMs in North America and selected European markets.
This unaudited Form 10-Q covers the three months ended March 31, 2012, with comparisons to the three months ended March 31, 2011. The company operates as one reportable segment. There were 10,091,822 common shares outstanding at March 31, 2012.
Key Financial Metrics
| Metric | Q1 2012 | Q1 2011 | Change |
|---|---|---|---|
| Net sales | $14.548 million | $11.498 million | +26.5% |
| Gross profit | $7.455 million | $5.954 million | +25.2% |
| Gross margin | 51.2% | 51.8% | Down 0.6 percentage points |
| Operating profit | $5.998 million | $1.264 million | +374.5% |
| Operating margin | 41.2% | 11.0% | Up 30.2 percentage points |
| Net income attributable to Omega Flex | $3.920 million | $0.819 million | +378.5% |
| Basic and diluted EPS | $0.39 | $0.08 | +$0.31 |
| Net cash provided by operating activities | $5.018 million | $(1.060) million | +$6.078 million |
| Capital expenditures | $0.038 million | None | Not comparable |
Net income was $3.923 million before the $3,000 allocation to the noncontrolling interest. Approximate net margin was 27.0% in Q1 2012 versus 7.1% in Q1 2011, substantially reflecting the insurance recovery described below.
Liquidity, Balance Sheet and Debt
- Cash and cash equivalents increased to $8.520 million at March 31, 2012 from $3.476 million at December 31, 2011, primarily because of the $4.700 million insurance legal recovery.
- Total current assets were $26.153 million and total current liabilities were $7.914 million at March 31, 2012. Approximate current ratio was 3.3x.
- Accounts receivable were $9.085 million and inventories were $6.870 million, compared with $9.052 million and $6.465 million, respectively, at December 31, 2011.
- Total liabilities were $9.659 million and shareholders’ equity was $26.910 million at quarter-end.
- The company had a $10.0 million revolving credit facility maturing December 31, 2014, with no borrowings outstanding at March 31, 2012. The company was in compliance with all debt covenants and had no cash interest payments during the quarter.
- Operating cash flow benefited from the insurance recovery and from higher accrued taxes and incentive compensation that had not yet been paid. Cash paid for income taxes was $47,000 in Q1 2012.
Material Changes Versus the Prior Comparable Period
- Sales increased $3.050 million, primarily from higher unit volume across most products, including significant growth in TracPipe CounterStrike, DoubleTrac and DEF-Trac. Management stated that pricing had little effect on the increase.
- Gross margin remained broadly stable, declining modestly to 51.2% from 51.8%.
- Selling expense increased $598,000 but remained relatively stable as a percentage of sales at 20.3% versus 20.5%.
- General and administrative expense increased $822,000 to $2.566 million, principally due to higher incentive compensation associated with increased profits and the insurance recovery.
- The company recorded a one-time $4.700 million insurance legal recovery in Q1 2012. Management stated that operating profit excluding the net insurance recovery was still more than 60% higher than in the prior-year quarter.
- Income tax expense increased to $2.137 million from $482,000; approximately $1.4 million of the increase related to the net insurance legal recovery.
- The company adopted revised comprehensive-income presentation guidance. The adoption affected presentation only and did not affect financial position, results of operations or cash flows.
Outlook, Risks, Contingencies and Unusual Items
- No specific numerical revenue, earnings or margin guidance is provided in the filing.
- Management cited growth in core and emerging products, continued product diversification and sales expansion in the United States and internationally, particularly the United Kingdom.
- Forward-looking results may be affected by weather, regulatory changes, customer preferences, general economic conditions, competition, litigation outcomes and environmental developments.
- Product-liability claims have increased in frequency over the prior two years. The company is defending the claims and believes they lack merit, but cannot estimate the ultimate liability. Insurance deductibles or self-insured retentions range from $25,000 to $250,000 per claim, depending on the policy year and terms.
- The company recorded $456,000 of accrued legal costs and claim settlements at March 31, 2012. Management stated that pending litigation could materially affect operations or liquidity, although no additional liability provision was recorded for matters whose outcome could not be estimated.
- In February 2012, an outside-party fraud involved approximately $400,000 of prepaid insurance premiums. Approximately $376,000 remained recorded in other long-term assets at March 31, 2012 and was held in a governmental custodial account. Recovery of all funds and any additional collection costs remain uncertain.
- An October 2010 product-liability case involving CSST and lightning resulted in a strict-liability jury verdict; the company appealed and the final outcome remained undetermined.
- The company extended its stock repurchase program on April 4, 2012, authorizing up to $1.0 million of additional repurchases without expiration. No repurchases occurred during Q1 2012.
- Management concluded that disclosure controls and procedures were effective and reported no material change in internal control over financial reporting during the quarter.
Investor Verification Checklist
- Separate recurring operating performance from the $4.700 million nonrecurring insurance legal recovery and related incentive compensation and taxes.
- Monitor the outcome and potential financial exposure from product-liability litigation, including the appealed CSST case.
- Verify recovery prospects for the approximately $376,000 insurance-premium-related asset and any related costs.
- Assess whether sales growth in CounterStrike, DoubleTrac, DEF-Trac and international markets is sustained.
- Review cash conversion after payment of accrued taxes, incentive compensation, commissions and other year-end obligations.
- Confirm continued covenant compliance, availability under the $10.0 million revolving credit facility and the company’s capital allocation under the extended repurchase authorization.